Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HITT: 90Y-Ibritumomab Tiuxetan With Stem Cells Support in B-cell Lymphoma
NCT00761384Phase 2Completed
- Sponsor
- Skåne University Hospital
- Start
- Apr 2008
- Primary completion
- Jan 2016
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of ibritumomab tiuxetan in B cell lymphoma, sponsored by Skåne University Hospital. Started Apr 2008; status: completed.
02
Drugs
ibritumomab tiuxetan
03
Conditions
B cell lymphoma
Beyond the preview
Go deeper on NCT00761384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00761384.